SECTION 1: Identification of the substance/mixture and of the company/undertaking. 1.1 Product identifier: Tris-TAPS Electrophoresis Buffer (mixture)

Transcription

1 Version: 1.0 Page 1 of 9 Revision date: SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1 Product identifier: Tris-TAPS Electrophoresis Buffer (mixture) Product name: Cat. No.: Other means of ID: 10X KBB electrophoresis buffer, 1 liter KBB1001 None Hazard components for labelling: None 1.2 Relevant identified uses of the substance or mixture and uses advised against Relevant identified uses: Used with Gel Electrophoresis of DNA. Uses advised against: Life sciences research only Details of the supplier of the safety data sheet: Supplier: Sage Science, Inc. 500 Cumming Center Suite 2400 Beverly, MA Tel: support@sagescience.com 1.4 EMERGENCY TELEPHONE NUMBER: (US)

2 Version: 1.0 Page 2 of 9 Revision date: SECTION 2: Hazards identification 2.1. Classification of the substance or mixture: Classification in accordance with 1272/2008 Upon assessment, this mixture is not classified as hazardous Label elements Label information in accordance with 1272/2008 Hazard pictograms: Signal words: Hazard statements: 2.3. Other hazards Not relevant. SECTION 3: Composition/information on ingredients CAS-No. EC-No. Classification according to Regulation (EC) No. 1272/2008 (CLP) Tris (hydroxymethyl)aminomethane (Tris) Concentration (wt/v) Not Classified <15% 3-(Tris(hydroxymethyl)methylamino)propane-1-sulphonic acid (TAPS) Not Classified <15% Ethylenediaminetetraacetic acid (EDTA) Not Classified <1% Water Not Classified >75%

3 Version: 1.0 Page 3 of 9 Revision date: SECTION 4: First Aid measures 4.1 Description of first aid measures General information Standard laboratory protection (coat, glasses and gloves) should be observed. Following inhalation Aqueous solution, no special measures are necessary. If inhalation occurs seek medical advice. Following skin contact Normal washing of skin is sufficient. If symptoms occur, seek medical advice. Following eye contact Rinse eyes thoroughly with water. If symptoms occur, seek medical advice. Following ingestion Rinse mouth with water. If symptoms occur, seek medical advice. Self-protection of the first aider:. 4.2 Most important symptoms and effects, both acute and delayed No further information is available 4.3 Indication of any immediate medical attention and special treatment needed. SECTION 5: Firefighting measures 5.1 Extinguishing media. 5.2 Special hazards arising from the substance or mixture. 5.3 Advice for fire-fighters.

4 Version: 1.0 Page 4 of 9 Revision date: SECTION 6: Accidental release measures 6.1 Personal precautions, protective equipment and emergency procedures For non-emergency personnel For emergency responders 6.2 Environmental precautions Non hazardous. Users should follow procedures and regulations set by their facility with regards to discharge. 6.3 Methods and material for containment and cleaning up Standard materials may be used (i.e paper towels, mop) 6.4 Reference to other sections. SECTION 7: Handling and storage 7.1 Precautions for safe handling Protective measures No special measures are required. Advice on general occupational hygiene Standard laboratory protection (coat, glasses and gloves) should be observed. 7.2 Conditions for safe storage, including any incompatibilities Technical measures and storage conditions Store at room temperature. No special measures are required. 7.3 Specific end uses Dilute 1:10 and use as electrophoresis buffer

5 Version: 1.0 Page 5 of 9 Revision date: SECTION 8: Exposure controls/personal protection 8.1 Control parameters All ingredients lack occupational exposure limit values 8.2 Exposure controls In terms of minimizing risks, no special attention is needed for this product besides the general obligation that follow EU directive 89/391 and national occupational legislation. Standard laboratory protection (coat, glasses and gloves) should be observed. SECTION 9: Physical and chemical properties 9.1 Information on basic physical and chemical properties Appearance: Clear Aqueous Liquid Physical state: Liquid Colour: Clear Odour: None Odour threshold: ph Melting point/freezing point Initial boiling point/boiling range Flash point Evaporation rate Flammability (solid, gas) Upper/lower flammability or explosive limits Upper explosive limits Lower explosive limits Vapour pressure Vapour density Relative density Solubility(ies) Partition coefficient: n-octanol/water Auto-ignition temperature Decomposition temperature Viscosity Viscosity, dynamic Viscosity, cinematic Explosive properties Oxidising properties Value Concentration Method Temperature Pressure Remark 9.2 Other information: No data available

6 Version: 1.0 Page 6 of 9 Revision date: SECTION 10: Stability and reactivity 10.1 Reactivity 10.2 Chemical stability The product is stable at normal storage and handling conditions 10.3 Possibility of hazardous reactions 10.4 Conditions to avoid: 10.5 Incompatible materials: 10.6 Hazardous decomposition products: SECTION 11: Toxicological information Acute toxicity EDTA: LC50 Rat (Oral) = 2000 mg/kg Tris and TAPS: No data available Eye damage/irritation To the best of our knowledge this product does not cause eye damage. May cause irritation with susceptible persons. Practical experience / human evidence In our experience there are no adverse affects from exposure to this product. Sensitisation to the respiratory tract To the best of our knowledge this product does not cause irritation to the respiratory tract. Skin sensitisation To the best of our knowledge this product does not cause skin irritation. CMR effects (carcinogenity, mutagenicity and toxicity for reproduction) To the best of our knowledge this product does not cause any CMR effects. Specific target organ toxicity (repeated exposure) To the best of our knowledge this product does not cause organ toxicity Aspiration hazard To the best of our knowledge this product is not an aspiration hazard. Symptoms related to the physical, chemical and toxicological characteristics:.

7 Version: 1.0 Page 7 of 9 Revision date: SECTION 12: Ecological information 12.1 Toxicity: Aquatic toxicity EDTA: LC50 Fish = >500 mg/l Tris and TAPS: No data available Sediment toxicity No data available Terrestrial toxicity No data available 12.2 Persistence and degradability No data available on persistence and degradability, but there is no reason to suppose the product is persistent Bioaccumulative potential No data available, but there is no reason to suppose the product bioaccumulates Mobility in soil No data available, but there is no reason to suppose the product is ecologically harmful Other adverse effects: The product and components have a very low global warming potential and no ozone depleting potential.

8 Version: 1.0 Page 8 of 9 Revision date: SECTION 13: Disposal considerations 13.1 Waste treatment methods Before intended use Properties of waste which render it hazardous: none Disposal operations: non hazardous, aqueous, use local regulations when disposing. Recovery operations: not applicable After intended use Properties of waste which render it hazardous: none Disposal operations: non hazardous, aqueous, use local regulations when disposing. Recovery operations: not applicable Polypropylene container can be recycled SECTION 14: Transport Information Where not otherwise stated the information applies to all of the UN Model Regulations, i.e. ADR (road). RID (railway), AND (inland waterways), IMDG (sea), and ICAO (IATA) (air)data sheet UN number Not classified as dangerous goods UN proper shipping name Transport hazard class(es) Packing group Environmental hazards Special precautions for user Transport in bulk according to Annex II of MARPOL73/78 and the IBC Code

9 Version: 1.0 Page 9 of 9 Revision date: SECTION 15: Regulatory information 15.1 Safety, health and environmental regulations/legislation specific for the substance or mixture 15.2 Chemical Safety Assessment For this product a chemical safety assessment is not required. SECTION 16: Other information 16.1 Indication of changes There are no earlier versions of this document 16.2 Abbreviations and acronyms Key literature references and sources for data Toxicity data for EDTA were obtained from the Toxicology Data Network provided by the US National Institute of Health (NIH) Training advice